vimarsana.com

விமானி மருத்துவ சிஇஆர்டிஐஎஃப்ஐசிஏடிஇ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FAA Approves Johnson & Johnson COVID-19 Vaccine

FAA Approves Johnson & Johnson COVID-19 Vaccine (Updated) The FAA has approved the Johnson & Johnson “one-shot” COVID-19 vaccine for pilots and others who “perform safety sensitive duties.” Previously, the agency had approved the Pfizer-BioNTech and Moderna vaccines and, as with those, the J&J alternative carries a brief waiting period before resuming duties. The approval came on the same day the FDA issued emergency approval for the vaccine. According to the FAA, “To maintain the highest level of safety in the National Airspace System, the FAA will require the affected recipients of this single-dose vaccine to wait 48 hours before conducting safety sensitive aviation duties, such as flying or controlling air traffic. The waiting period, which accounts for potential side effects, applies to those holding an Airman Medical Certificate issued under 14 CFR Part 67 or a Medical Clearance issued under FAA Order 3930.3C.” For commercial pilots and controllers, the one-dose va

Pilots may receive Johnson & Johnson s vaccine, with appropriate precautions

Pilots may receive Johnson & Johnson’s vaccine, with appropriate precautions FAA Press Release | March 1, 2021 Estimated reading time 2 minutes, 14 seconds. Following the Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for Johnson & Johnson’s Janssen COVID-19 vaccine, the Federal Aviation Administration (FAA) has determined that pilots and others who perform safety sensitive duties may receive the vaccine under the conditions of their FAA-issued airman medical certification. FAA and contract air traffic controllers, who are subject to FAA medical clearance, may also receive the vaccine. To maintain the highest level of safety in the National Airspace System, the FAA will require the affected recipients of this single-dose vaccine to wait 48 hours before conducting safety sensitive aviation duties, such as flying or controlling air traffic. The waiting period, which accounts for potential side effects, applies to those holding an Airman Medic

Pilots and air traffic controllers to be monitored for 48 hours after taking coronavirus vaccine to ensure aviation safety

https://www.afinalwarning.com/490121.html (Natural News) Although the Food and Drug Administration (FDA) has deemed the coronavirus vaccine safe for use, the Federal Aviation Administration (FAA) chooses to err on the side of caution. The policy was released a day after the FDA granted emergency use authorization for mRNA-1273 or the Moderna vaccine. Pfizer-BioNTech’s vaccine received FDA authorization on Dec. 11 and the FAA permitted its use on Dec. 12. The FAA Office of Aerospace Medicine said: “Holders of FAA-issued Airman Medical Certificates or Medical Clearances may receive the Pfizer-BioNTech or Moderna COVID-19 vaccine. However, a 48-hour no fly/no [safety-related] duty interval must be observed after each dose.”

Pilots and air traffic controllers may receive Moderna vaccine, with appropriate precautions

Pilots and air traffic controllers may receive Moderna vaccine, with appropriate precautions FAA Press Release | December 20, 2020 Estimated reading time 2 minutes, 32 seconds. Following the Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for Moderna’s COVID-19 vaccine, the FAA has determined that pilots may receive the vaccine under the conditions of their FAA-issued airman medical certification. FAA air traffic controllers, who are subject to FAA medical clearance, may also receive the vaccine. To maintain the highest level of safety in the National Airspace System, the agency will require pilots with medical certifications or air traffic controllers with medical clearances to observe a period of 48 hours following the administration of each dose of this vaccine before conducting safety-sensitive aviation duties, such as flying or controlling air traffic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.